Dr M L Dhawale Memorial Homeopathic Institute Profile
Key Indicators
- Company Age 21 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 8.64%
(FY 2020)
- Profit 248.21%
(FY 2020)
- Ebitda 17.36%
(FY 2020)
- Net Worth 1.15%
(FY 2020)
- Total Assets 1.62%
(FY 2020)
About Dr M L Dhawale Memorial Homeopathic Institute
The Company is engaged in the Education Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.00 and a paid-up capital of Rs 0.00, as per Ministry of Corporate Affairs (MCA) records.
Kumar Mitrachandra, Kamlesh Shah, Manoj Patel, and Three other members serve as directors at the Company.
- CIN/LLPIN
U85193MH2003NPL139332
- Company No.
139332
- Company Classification
Public Not For Profit Company
- Incorporation Date
25 Feb 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dr M L Dhawale Memorial Homeopathic Institute?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kumar Mitrachandra  | Managing Director | 25-Feb-2003 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kamlesh Shah | Director | 18-Jul-2004 | Current |
| Manoj Patel | Director | 06-Jun-2022 | Current |
| Anoop Nigwekar | Director | 06-Jun-2022 | Current |
| Shashank Shah | Director | 06-Jun-2022 | Current |
| Umesh Sanghvi | Director | 18-Jul-2004 | Current |
Financial Performance of Dr M L Dhawale Memorial Homeopathic Institute.
Dr M L Dhawale Memorial Homeopathic Institute, for the financial year ended 2020, experienced modest growth in revenue, with a 8.64% increase. The company also saw a substantial improvement in profitability, with a 248.21% increase in profit. The company's net worth moved up by a moderate rise of 1.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr M L Dhawale Memorial Homeopathic Institute?
Unlock access to Dr M L Dhawale Memorial Homeopathic Institute's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dr M L Dhawale Memorial Homeopathic Institute?
Dr M L Dhawale Memorial Homeopathic Institute has a workforce of 74 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr M L Dhawale Memorial Homeopathic Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr M L Dhawale Memorial Homeopathic Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
